Ultrasound Abdomen is the Most Appropriate Screening Test
For a 27-year-old man with a sister who has ADPKD, abdominal ultrasound is the recommended first-line screening test. 1
Rationale Based on 2025 KDIGO Guidelines
The 2025 KDIGO Clinical Practice Guideline explicitly recommends abdominal imaging by ultrasound to screen adults at risk of ADPKD who have a positive family history 1. This patient fits this exact scenario—he is an at-risk adult (27 years old) with a first-degree relative (sister) affected by the disease.
Age-Specific Diagnostic Criteria
For this 27-year-old patient, the ultrasound diagnostic criteria are straightforward:
- ≥3 total kidney cysts confirms ADPKD (ages 15-39 years)
- ≤1 cyst rules out ADPKD (ages 15-39 years)
- Equivocal findings (2 cysts total) would warrant follow-up with MRI or genetic testing 1
Why Not the Other Options?
CT abdomen is not appropriate for initial screening because:
- It exposes the patient to unnecessary ionizing radiation
- It is reserved for detecting complications (hemorrhage, infection, rupture) rather than diagnosis 2
- While CT can be used as an alternative to MRI for equivocal cases, it is not the first-line screening modality 1
Urine microscopy has no role in screening or diagnosing ADPKD—it does not detect cysts and is not mentioned in any diagnostic algorithm 1
Anti-polycystin 1 antibodies do not exist as a clinical diagnostic test. ADPKD is diagnosed through imaging or genetic testing for PKD1/PKD2 gene mutations, not through antibody testing 1
Clinical Algorithm for This Patient
- First step: Renal ultrasound (non-invasive, no radiation, cost-effective)
- If ≥3 cysts detected: ADPKD diagnosis confirmed—proceed to clinical management and prognostication
- If 0-1 cyst: ADPKD effectively ruled out at this age
- If 2 cysts (equivocal): Consider MRI (>10 cysts confirms, <5 cysts rules out for ages 16-40) or genetic testing for PKD1/PKD2 mutations 1
Important Caveats
Pre-test counseling is essential before performing any screening test 1. The patient should understand:
- The implications of a positive diagnosis (insurance, employment, psychological impact)
- The benefits of early diagnosis (blood pressure monitoring, lifestyle modifications, potential for disease-modifying therapy)
- The option to defer testing if he prefers not to know his status
Genetic testing is reserved for specific situations in this context 1:
- Equivocal imaging findings
- If he were being considered as a living kidney donor
- Family planning decisions
- If the family's genetic variant is already known (targeted testing is simpler)
Diagnostic Performance
Ultrasound has excellent diagnostic accuracy in this age group. High-resolution ultrasound achieves approximately 97% sensitivity and 98% specificity for detecting ADPKD in at-risk individuals aged 16-40 years 3. MRI offers 100% sensitivity and specificity with >10 cysts as the threshold, but is more expensive and not necessary as first-line screening 3.
The bottom line: Proceed with renal ultrasound as the initial screening test, ensuring appropriate pre-test counseling about the implications of testing.